Thyroid Eye Disease (TED) is 16 per 100,000 females and 2.9 per 100,000 males in India. TED is the most common extra-thyroidal manifestation of Graves’ Disease. Retrobulbar irradiation is an important part of therapy. The National Institute for Health and Clinical Excellence (NICE) has issued guidelines on retrobulbar irradiation for TED.
Thyroid eye disease (also known as dysthyroid eye disease, Graves' eye disease, Graves' ophthalmopathy, or thyroid orbitopathy) is a disease which predominantly affects the extraocular muscles. Signs and symptoms include proptosis, retro-orbital pain, tearing, ocular soft tissues inflammation, eyelid retraction, conjunctival redness and edema, corneal lesions, impaired extraocular motility with or without diplopia, periorbital edema, visual impairment and rarely, blindness. Treatment of TED Treatment options for TED include immunosuppressive agents,…
